Tianjin Chase Sun Pharmaceutical: 2024 First Quarter Report Disclosure Prompt Announcement
Hongri Pharmaceutical: Notice on the Company's Completion of the Registration of the Legal Representative's Change of Trade
Hongri Pharmaceutical: Legal Opinion of the 2023 Annual General Meeting of Shareholders
Hongri Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hongri Pharmaceutical: Legal Opinion of the Third Extraordinary General Meeting of Shareholders in 2024
Hongri Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Hongri Pharmaceutical: Interim Report of Tianfeng Securities Co., Ltd. on the fiduciary management matters of the resignation of the chairman of Tianjin Hongri Pharmaceutical Co., Ltd. and the by-election of directors, chairman, vice chairman, adjustment o
Hongri Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Hongri Pharmaceutical: Announcement on the Resignation of the Chairman of the Company and the By-election of Directors, Chairman of the Board, Vice Chairman, Adjustment of Special Committee Members, Changes in Legal Representatives, and Appointment of Comp
Hongri Pharmaceutical: Legal Opinion of the 2024 Second Extraordinary General Meeting of Shareholders
Hongri Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Hongri Pharmaceutical: 2023 Annual Financial Report
Hongri Pharmaceutical: 2023 Internal Control Self-Assessment Report
Hongri Pharmaceutical: Notice on Convening the 2023 Annual General Meeting of Shareholders
Hongri Pharmaceutical: Summary table of the company's non-operating capital occupation and other related capital transactions in 2023
Hongri Pharmaceutical: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Hongri Pharmaceutical: Prompt Announcement for Disclosure of the 2023 Annual Report
Hongri Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Hongri Pharmaceutical: Announcement on By-election of Non-Independent Directors for the 8th Board of Directors of the Company
Hongri Pharmaceutical: Legal Opinion of the 2024 First Extraordinary General Meeting of Shareholders
No Data